课题基金 / 基金详情

项目摘要

项目成果

Juan Botas的其他基金

相似基金

相关文献

中文摘要
翻译
该项目的最终目标是确定 发病机制和潜在的治疗目标是共同的脊髓小脑 共济失调(SCA)。这是一组约30种遗传异质性神经退行性疾病, 具有神经病理学和临床特征的疾病,例如 小脑和运动协调和平衡的丧失。 最近的数据表明遗传性共济失调之间存在未知的联系。首先是蛋白质蛋白质 遗传性共济失调的相互作用网络显示,许多引起共济失调的 蛋白质共享相互作用的伙伴。第二,dAtaxin-2(蛋白质的直向同源物 负责SCA 2)是共济失调蛋白-1(82 Q)诱导的神经毒性的主要修饰剂, SCA 1的果蝇模型。总之,这些观察表明, 也许其他遗传性共济失调可能有着共同的发病机制, 除了相似的神经病理学和临床特征之外。这一假说预测, SCA具有共同的遗传修饰剂和潜在的治疗靶点, 未知检验这一假设需要对遗传修饰剂进行彻底的比较 不同遗传性共济失调的发病机制。 将采用遗传学方法来确定神经毒性的修饰剂, 通过扩增的Ataxin-1、Ataxin-2和Ataxin-7, SCA7。本报告所建议的工作将针对以下具体目标: 研究dAtaxin-2功能部分丧失的分子机制, 抑制Ataxin-1[82 Q]诱导的神经变性。2)为了筛查共济失调 共济失调蛋白-1 [82 Q]诱导的神经毒性的遗传修饰剂的相互作用组。3)测试 共济失调蛋白-1 [82 Q]遗传修饰物和果蝇模型中的共济失调相互作用组 SCA 2和SCA 7。4)为了研究选定的遗传修饰剂, 果蝇SCA模型。 用哺乳动物模型进行这些比较研究是不切实际的,但却是可行的。 使用果蝇。由此确定的神经变性抑制因子 工作可以直接指向特定的治疗靶点。这些基础研究是 开发治疗这些神经退行性疾病的疗法的先决条件, 没有有效的治疗方法。
英文摘要
The ultimate goal of this project is to identify molecular mechanisms of pathogenesis and potential therapeutic targets that are common to Spinocerebellar ataxias (SCAs). These are a group ~30 genetically heterogeneous neurodegenerative disorders that share neuropathological and clinical features such as atrophy of the cerebellum and loss of motor coordination and balance. Recent data points to unsuspected links among inherited ataxias. First, a proteinprotein- interaction network for inherited ataxias revealed that many ataxia-causing proteins share interacting partners. Second, dAtaxin-2 (an orthologue of the protein responsible for SCA2) is a major modifier of Ataxin-1[82Q]-induced neurotoxicity in a Drosophila model of SCA1. Together, these observations suggest that SCAs, and perhaps other inherited ataxias may share molecular mechanisms of pathogenesis in addition to similar neuropathology and clinical features. This hypothesis predicts that SCAs have common genetic modifiers and potential therapeutic targets that remain unknown. Testing this hypothesis requires a thorough comparison of genetic modifiers and mechanisms of pathogenesis among different inherited ataxias. A genetic approach will be employed to identify modifiers of neurotoxicity caused by expanded Ataxin-1, Ataxin-2 and Ataxin-7, the proteins responsible for SCA1, SCA2 an SCA7. The work proposed here will address the following specific aims: 1) To investigate the molecular mechanisms by which partial loss of dAtaxin-2 function suppresses Ataxin-1[82Q]-induced neurodegeneration. 2) To screen the ataxia interactome for genetic modifiers of Ataxin-1[82Q]-induced neurotoxicity. 3) To test the Ataxin-1[82Q] genetic modifiers and the ataxia interactome in Drosophila models of SCA2 and SCA7. 4) To investigate selected genetic modifiers that are common to the Drosophila SCA models. These comparative studies are impractical with mammalian models, but feasible using Drosophila. The suppressors of neurodegeneration identified as a result of this work may directly point to specific therapeutic targets. These basic studies are prerequisite to developing therapies for these neurodegenerative disorders for which there are no effective treatments.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Functional Dissection of Alzheimer's Disease Networks in Drosophila: from Association to Causal Modulators of Age-Dependent Neurodegeration
  • 批准号:
    10228292
  • 项目类别:
  • 资助金额:
    $13.67万
  • 财政年份:
    2017
  • 负责人:
    Juan Botas
  • 依托单位:
Neurodegeneration with Drosophila
  • 批准号:
    6540512
  • 项目类别:
  • 资助金额:
    $44.51万
  • 财政年份:
    2001
  • 负责人:
    Juan Botas
  • 依托单位:
Neurodegeneration with Drosophila
  • 批准号:
    6769927
  • 项目类别:
  • 资助金额:
    $33.86万
  • 财政年份:
    2001
  • 负责人:
    Juan Botas
  • 依托单位:
Probing Neurodegeneration with Drosophila
  • 批准号:
    8098002
  • 项目类别:
  • 资助金额:
    $32.91万
  • 财政年份:
    2001
  • 负责人:
    Juan Botas
  • 依托单位:
海外基金